BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity

NCT01603615 PHASE3 COMPLETED Results posted

This study will evaluate the long-term safety of BOTOX® (botulinum toxin Type A) for the treatment of pediatric upper limb spasticity.

Details

Lead sponsor	Allergan
Phase	PHASE3
Status	COMPLETED
Enrolment	220
Start date	Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Sep 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Pediatrics
• Muscle Spasticity
• Cerebral Palsy
• Stroke

Interventions

• Botulinum Toxin Type A

Countries

Russia, Poland, Hungary, Philippines, South Korea, Canada, Thailand, United States, Turkey (Türkiye)